Biogen (NASDAQ:BIIB) outlined its immunology and neurology development priorities during a virtual symposium hosted by Piper Sandler, with Dr. Diana Gallagher, head of clinical development for MS, ...

Biogen BIIB will report fourth-quarter and full-year 2025 results on Feb. 6, before market open. In the last reported quarter, the company's earnings beat expectations by 23.65%. The Zacks Consensus ...

January 2016, a decade ago this week, was the last time I drank. Not that I knew it was the last drink at the time. “Never again” was as much part of my vocabulary as “shall we get another?” (a ...

I need to remind myself that relapsing will not help anything. Picking up again may bring some immediate comfort in these disorienting, fraught, and perilous times. But that comfort is illusory, a ...

Lulu opens up about fears of relapsing after revealing alcoholism battle - The Trump administration might’ve gone one power grab too far Why Elon Musk says saving for retirement will be 'irrelevant' ...

JACKSONVILLE, Fla. — For many, the holiday season brings celebration, travel and time with loved ones. But for people in recovery from substance use, it can also bring disrupted routines, heightened ...

In a trial, rituximab demonstrated clinical efficacy in reducing proteinuria in patients with FRNS or SDNS. Intravenous rituximab is safe and effective in patients with frequently relapsing nephrotic ...

Researchers have uncovered microbial evidence in the remains of Napoleon’s soldiers from the 1812 Russian retreat. Genetic analysis revealed pathogens behind paratyphoid and relapsing fever, diseases ...